Evidence map›Paper›PMID 31584242›Full record

ArticleEMBO reports2019

Apicomplexan F-actin is required for efficient nuclear entry during host cell invasion.

Mario Del Rosario, Javier Periz, Georgios Pavlou, Oliver Lyth, Fernanda Latorre-Barragan, Sujaan Das, Gurman S Pall, Johannes Felix Stortz, Leandro Lemgruber, Jamie A Whitelaw and 3 more

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Architecture of theProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 4 countries.

Mario Del RosarioWellcome Centre For Integrative Parasitology, Institute of Infection, Immunity & Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, UK.ORCID 0000-0002-0430-1463
Javier PerizWellcome Centre For Integrative Parasitology, Institute of Infection, Immunity & Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, UK.
Georgios PavlouInstitute for Advanced Biosciences, CNRS, UMR5309, INSERM U1209, Université Grenoble Alpes, Grenoble, France.
Oliver LythDepartment of Life Sciences, Imperial College London, London, UK.
Fernanda Latorre-BarraganWellcome Centre For Integrative Parasitology, Institute of Infection, Immunity & Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, UK.ORCID 0000-0002-9280-705X
Sujaan DasWellcome Centre For Integrative Parasitology, Institute of Infection, Immunity & Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, UK.
Gurman S PallWellcome Centre For Integrative Parasitology, Institute of Infection, Immunity & Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, UK.
Johannes Felix StortzWellcome Centre For Integrative Parasitology, Institute of Infection, Immunity & Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, UK.ORCID 0000-0002-5928-1850
Leandro LemgruberWellcome Centre For Integrative Parasitology, Institute of Infection, Immunity & Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, UK.
Jamie A WhitelawCRUK Beatson Institute, Glasgow, UK.
Jake BaumDepartment of Life Sciences, Imperial College London, London, UK.ORCID 0000-0002-0275-352X
Isabelle TardieuxInstitute for Advanced Biosciences, CNRS, UMR5309, INSERM U1209, Université Grenoble Alpes, Grenoble, France.ORCID 0000-0002-5677-7463
Markus MeissnerWellcome Centre For Integrative Parasitology, Institute of Infection, Immunity & Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, UK.ORCID 0000-0002-4816-5221
Wellcome Centre for Molecular Parasitology · GBCentre National de la Recherche Scientifique · FRImperial College London · GBCancer Research UK Scotland Institute · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

The obligate intracellular parasites Toxoplasma gondii and Plasmodium spp. invade host cells by injecting a protein complex into the membrane of the targeted cell that bridges the two cells through the assembly of a ring-like junction. This circular junction stretches while the parasites apply a traction force to pass through, a step that typically concurs with transient constriction of the parasite body. Here we analyse F-actin dynamics during host cell invasion. Super-resolution microscopy and real-time imaging highlighted an F-actin pool at the apex of pre-invading parasite, an F-actin ring at the junction area during invasion but also networks of perinuclear and posteriorly localised F-actin. Mutant parasites with dysfunctional acto-myosin showed significant decrease of junctional and perinuclear F-actin and are coincidently affected in nuclear passage through the junction. We propose that the F-actin machinery eases nuclear passage by stabilising the junction and pushing the nucleus through the constriction. Our analysis suggests that the junction opposes resistance to the passage of the parasite's nucleus and provides the first evidence for a dual contribution of actin-forces during host cell invasion by apicomplexan parasites.

Indexed as

ActinsActive Transport, Cell NucleusAnimalsCell NucleusCells, CulturedGene Knockout TechniquesHost-Parasite InteractionsHumansMerozoitesModels, BiologicalMutationPlasmodium falciparumProtozoan ProteinsSignal TransductionToxoplasmaVirulenceActinsProtozoan ProteinsactinApicomplexahost cell invasionmyosinnucleus

Identifiers

PMID31584242
PMCPMC6893294
OpenAlexW2977519297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.